Literature DB >> 31524867

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System.

Lance Daharsh1, Jianshui Zhang1, Amanda Ramer-Tait2, Qingsheng Li3.   

Abstract

Humanized mice (hu-mice) that feature a functional human immune system have fundamentally changed the study of human pathogens and disease. They can be used to model diseases that are otherwise difficult or impossible to study in humans or other animal models. The gut microbiome can have a profound impact on human health and disease. However, the murine gut microbiome is very different than the one found in humans.  There is a need for improved pre-clinical hu-mice models that have an engrafted human gut microbiome. Therefore, we created double hu-mice that feature both a human immune system and stable human-like gut microbiome. NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice are one of the best animals for humanization due to their high level of immunodeficiency. However, germ-free NSG mice, and various other important germ-free mice models are not currently commercially available. Further, many research settings do not have access to gnotobiotic facilities, and working under gnotobiotic conditions can often be expensive and time consuming. Importantly, germ-free mice have several immune deficiencies that exist even after the engraftment of microbes. Therefore, we developed a protocol that does not require germ-free animals or gnotobiotic facilities. To generate double hu-mice, NSG mice were treated with radiation prior to surgery to create bone-marrow, liver, thymus-humanized (hu-BLT) mice. The mice were then treated with broad spectrum antibiotics to deplete the pre-existing murine gut microbiome. After antibiotic treatment, the mice were given fecal transplants with healthy human donor samples via oral gavage. Double hu-BLT mice had unique 16S rRNA gene profiles based on the individual human donor sample that was transplanted. Importantly, the transplanted human-like microbiome was stable in the double hu-BLT mice for the duration of the study up to 14.5 weeks post-transplant.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31524867      PMCID: PMC7009290          DOI: 10.3791/59773

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  32 in total

Review 1.  Reciprocal interactions of the intestinal microbiota and immune system.

Authors:  Craig L Maynard; Charles O Elson; Robin D Hatton; Casey T Weaver
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

2.  Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer.

Authors:  Korry J Hintze; James E Cox; Giovanni Rompato; Abby D Benninghoff; Robert E Ward; Jeff Broadbent; Michael Lefevre
Journal:  Gut Microbes       Date:  2014-03-05

3.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

4.  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors:  Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

5.  VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.

Authors:  Georg Stary; Andrew Olive; Aleksandar F Radovic-Moreno; David Gondek; David Alvarez; Pamela A Basto; Mario Perro; Vladimir D Vrbanac; Andrew M Tager; Jinjun Shi; Jeremy A Yethon; Omid C Farokhzad; Robert Langer; Michael N Starnbach; Ulrich H von Andrian
Journal:  Science       Date:  2015-06-19       Impact factor: 47.728

6.  Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.

Authors:  Michelle R Simpson-Abelson; Gregory F Sonnenberg; Hiroshi Takita; Sandra J Yokota; Thomas F Conway; Raymond J Kelleher; Leonard D Shultz; Maurice Barcos; Richard B Bankert
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Humanized mice as a model for aberrant responses in human T cell immunotherapy.

Authors:  Nalini K Vudattu; Frank Waldron-Lynch; Lucy A Truman; Songyan Deng; Paula Preston-Hurlburt; Richard Torres; Maurice T Raycroft; Mark J Mamula; Kevan C Herold
Journal:  J Immunol       Date:  2014-06-18       Impact factor: 5.422

8.  Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.

Authors:  Zhifeng Sun; Paul W Denton; Jacob D Estes; Florence A Othieno; Bangdong L Wei; Anja K Wege; Michael W Melkus; Angela Padgett-Thomas; Mary Zupancic; Ashley T Haase; J Victor Garcia
Journal:  J Exp Med       Date:  2007-03-26       Impact factor: 14.307

9.  Variable Colonization after Reciprocal Fecal Microbiota Transfer between Mice with Low and High Richness Microbiota.

Authors:  Aaron C Ericsson; Alexa R Personett; Giedre Turner; Rebecca A Dorfmeyer; Craig L Franklin
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

10.  Selective colonization ability of human fecal microbes in different mouse gut environments.

Authors:  Wei Zhou; Kin-Hoe Chow; Elizabeth Fleming; Julia Oh
Journal:  ISME J       Date:  2018-11-15       Impact factor: 10.302

View more
  6 in total

Review 1.  Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses.

Authors:  Amy Gillgrass; Jocelyn M Wessels; Jack X Yang; Charu Kaushic
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

Review 2.  Humanized Mice for the Evaluation of Novel HIV-1 Therapies.

Authors:  Shawn Abeynaike; Silke Paust
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

3.  Host Immunity Influences the Composition of Murine Gut Microbiota.

Authors:  Vincent Van Averbeke; Matilda Berkell; Mohamed Mysara; Juan Pablo Rodriguez-Ruiz; Basil Britto Xavier; Fien H R De Winter; Bart 's Jongers; Ravi Kumar Jairam; An Hotterbeekx; Herman Goossens; E Suzanne Cohen; Surbhi Malhotra-Kumar; Samir Kumar-Singh
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

Review 4.  Interspecies Communication in Holobionts by Non-Coding RNA Exchange.

Authors:  Ana Lúcia Leitão; Marina C Costa; André F Gabriel; Francisco J Enguita
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 5.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21

6.  Donor Microbiota Composition and Housing Affect Recapitulation of Obese Phenotypes in a Human Microbiota-Associated Murine Model.

Authors:  Thomas Kaiser; Harika Nalluri; Zhigang Zhu; Christopher Staley
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.